Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes

Bibliographic Details
Main Authors: Carmen Hierro-Bujalance, Monica Garcia-Alloza
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Neural Regeneration Research
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1189;epage=1190;aulast=Hierro-Bujalance
_version_ 1827300176934469632
author Carmen Hierro-Bujalance
Monica Garcia-Alloza
author_facet Carmen Hierro-Bujalance
Monica Garcia-Alloza
author_sort Carmen Hierro-Bujalance
collection DOAJ
first_indexed 2024-04-24T15:48:49Z
format Article
id doaj.art-0db36636004d465a91b2e00cea269320
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-04-24T15:48:49Z
publishDate 2024-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-0db36636004d465a91b2e00cea2693202024-04-01T13:05:58ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742024-01-011961189119010.4103/1673-5374.385865Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetesCarmen Hierro-BujalanceMonica Garcia-Allozahttp://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1189;epage=1190;aulast=Hierro-Bujalance
spellingShingle Carmen Hierro-Bujalance
Monica Garcia-Alloza
Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes
Neural Regeneration Research
title Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes
title_full Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes
title_fullStr Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes
title_full_unstemmed Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes
title_short Empagliflozin reduces brain pathology in Alzheimer’s disease and type 2 diabetes
title_sort empagliflozin reduces brain pathology in alzheimer s disease and type 2 diabetes
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=6;spage=1189;epage=1190;aulast=Hierro-Bujalance
work_keys_str_mv AT carmenhierrobujalance empagliflozinreducesbrainpathologyinalzheimersdiseaseandtype2diabetes
AT monicagarciaalloza empagliflozinreducesbrainpathologyinalzheimersdiseaseandtype2diabetes